Loading clinical trials...
Loading clinical trials...
To assess the efficacy and safety of OTX-DED for the short-term treatment of signs and symptoms of dry eye disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ocular Therapeutix, Inc.
NCT07656688 · Dry Eye Disease (DED)
NCT07605572 · Dry Eye Disease (DED), Diabete Mellitus, and more
NCT07579130 · Dry Eye
NCT07566975 · Dry Eye
NCT06220474 · Dry Eye Syndromes, Meibomian Gland Dysfunction
Ocular Therapeutix
Inglewood, California
Ocular Therapeutix, Inc
Mission Hills, California
Ocular Therapeutix, Inc.
Newport Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions